Fresenius Kabi Recalls Benztropine Mesylate Injection Due to Glass Particulates
Fresenius Kabi is recalling 65,110 vials of Benztropine Mesylate Injection due to the presence of glass particulate matter. The affected vials were distributed nationwide and in Puerto Rico.
- Product
- BENZTROPINE MESYLATE — BENZTROPINE MESYLATE (BENZTROPINE MESYLATE)
- Category
- Drug
- Distribution
- Distributed nationwide